Navigation Links
SoluLinK Introduces NanoLink(TM) Streptavidin Magnetic Microspheres
Date:5/28/2008

SAN DIEGO, May 28 /PRNewswire/ -- SoluLinK, Inc., a leader in next-generation conjugation products and kits, is proud to announce the introduction of a new product, NanoLink(TM) Streptavidin Magnetic Microspheres. These sub-micron particles possess the highest biotin-binding capacity of any commercially available polymer-encapsulated streptavidin magnetic microsphere. NanoLink(TM) Streptavidin particles are particularly suited for high throughput robotic applications where high biotin loads must be removed or immobilized without the presence of an iron leachate. Features and Benefits include:

-- Highest free-biotin binding capacity > 12 nmol/mg

-- Highest biotin-oligonucleotide binding capacity > 2.5 nmol/mg

-- Highest biotin-IgG binding capacity > 1.7 nmol/mg (250 ug)

-- Higher capacity means less mass and lower background (NSB)

-- Higher capacity means significantly lower net costs

-- Encapsulated (no exposed iron) polymeric microspheres

-- Fast magnetic response time (1-2 minutes)

(Photo: http://www.newscom.com/cgi-bin/prnh/20080528/LAW512)

"NanoLink(TM) Streptavidin Magnetic Microspheres represent a continuation of our development efforts in leveraging SoluLinK's next-generation conjugation technology into formats that enable our customers' and collaborators' to build greater value into their products and research," observed Leo Mendoza, Director of Product Development.

About SoluLinK

SoluLinK is a leader in the development, manufacturing and marketing of advanced conjugation reagents (HydraLink(TM)) biotinylation kits (ChromaLink(TM)), magnetic microspheres (NanoLink(TM)), detection reagents and conjugating services for the life sciences, diagnostic, and pharmaceutical communities. The company's proprietary bioconjugation chemistry is used to link proteins, oligonucleotides, peptides, and antibodies to each other or to a wide range of surfaces. Rapidly growing applications for SoluLinK's products include the conjugation of biomolecules used in research assays, diagnostics, and various pharmaceutical products. The company markets its products directly and through partner-associated distributors world-wide. Technology licenses are available. SoluLinK is a privately held company located in San Diego, California. For more information, please visit http://www.solulink.com.


'/>"/>
SOURCE SoluLinK, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SoluLinK Introduces ChromaLink(TM) Biotin Labeling Kit to Biotinylate and Measure With One Reagent
2. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
3. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
4. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
5. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
6. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
7. Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology
8. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
9. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
10. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
11. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CA (PRWEB) , ... June 27, 2016 , ... ... for clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT ... care circle with the physician and clinical trial team. , Using the CONSULT module, ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
Breaking Biology News(10 mins):